RA CAPITAL MANAGEMENT, L.P. sold 40.8% of their position (4.18M shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $58.38M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/10/2025ACC: 0001231919-25-000596
10% Owner
Since Aug 2022
-4.18M
Net shares
Net seller
$58.38M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.18M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−1.38M
Price / share
$13.33
Trade value
$18.36M
% of position
13.5%
12/8/2025
10.23M→8.85M
Common Stock
Indirect
Shares
−2.71M
Price / share
$14.28
Trade value
$38.65M
% of position
30.6%
12/8/2025
8.85M→6.15M
Common Stock
Indirect
Shares
−91.72K
Price / share
$14.98
Trade value
$1.37M
% of position
1.5%
12/8/2025
6.15M→6.05M
Total
Net shares
−4.18M
Net value
-$58.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/8/2025 | S · Sale | −1.38M | $13.33 | $18.36M | 13.5% | 10.23M | 8.85M |
| Common Stock Indirect | 12/8/2025 | S · Sale | −2.71M | $14.28 | $38.65M | 30.6% | 8.85M | 6.15M |
| Common Stock Indirect | 12/8/2025 | S · Sale | −91.72K | $14.98 | $1.37M | 1.5% | 6.15M | 6.05M |
| Total | −4.18M | -$58.38M | ||||||
Derivative Transactions0
No derivative transactions reported